ILLENA BOGGS: Open Payments
NPI 1790145191 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 43 payments from 12 companies in 2025. Trend: 2023 $441 · 2024 $584 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $241 |
| ABBVIE INC. | 16 | $154 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Corcept Therapeutics | 3 | $57 |
| Abbott Laboratories | 2 | $34 |
| Dexcom, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: VRAYLAR, Wegovy, TRELEGY ELLIPTA, Ozempic, Rybelsus, Korlym, FREESTYLE LIBRE 3, Dexcom G6 Transmitter.
Industry payments across KY — which companies pay providers there.
